- Home
- IMUX vs ASYS Comparison
IMUX vs ASYS Comparison
Compare IMUX & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- ASYS
- Stock Information
- Founded
- IMUX 2016
- ASYS 1981
- Country
- IMUX United States
- ASYS United States
- Employees
- IMUX N/A
- ASYS N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- ASYS Industrial Machinery/Components
- Sector
- IMUX Health Care
- ASYS Technology
- Exchange
- IMUX Nasdaq
- ASYS Nasdaq
- Market Cap
- IMUX 67.8M
- ASYS 59.4M
- IPO Year
- IMUX N/A
- ASYS N/A
- Fundamental
- Price
- IMUX $0.96
- ASYS $4.62
- Analyst Decision
- IMUX Strong Buy
- ASYS
- Analyst Count
- IMUX 5
- ASYS 0
- Target Price
- IMUX $7.50
- ASYS N/A
- AVG Volume (30 Days)
- IMUX 1.1M
- ASYS 36.1K
- Earning Date
- IMUX 08-11-2025
- ASYS 08-06-2025
- Dividend Yield
- IMUX N/A
- ASYS N/A
- EPS Growth
- IMUX N/A
- ASYS N/A
- EPS
- IMUX N/A
- ASYS N/A
- Revenue
- IMUX N/A
- ASYS $90,826,000.00
- Revenue This Year
- IMUX N/A
- ASYS N/A
- Revenue Next Year
- IMUX N/A
- ASYS $28.60
- P/E Ratio
- IMUX N/A
- ASYS N/A
- Revenue Growth
- IMUX N/A
- ASYS N/A
- 52 Week Low
- IMUX $0.56
- ASYS $3.20
- 52 Week High
- IMUX $2.11
- ASYS $6.81
- Technical
- Relative Strength Index (RSI)
- IMUX 55.60
- ASYS 52.82
- Support Level
- IMUX $0.94
- ASYS $4.50
- Resistance Level
- IMUX $1.18
- ASYS $4.85
- Average True Range (ATR)
- IMUX 0.08
- ASYS 0.27
- MACD
- IMUX 0.01
- ASYS -0.02
- Stochastic Oscillator
- IMUX 40.95
- ASYS 46.55
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.